人类子宫移植是否能够广泛开展?

2016-06-07 杨一苗 蔡馨逸 新华社

西京医院日前宣布,我国第一例“人子宫”移植手术获得成功。

西京医院日前宣布,我国第一例“人子宫”移植手术获得成功。

2013年,就读于西安某高校护理学专业的杨女士因从未来过“例假”,到西京医院妇产科就诊,随后出来的B超结果却让杨女士天旋地转:先天性无子宫无阴道。

据西京医院妇产科主任陈必良介绍,这名患者虽然有卵巢能够产生卵子,但由于缺少让受精卵生长发育成胎儿的子宫,她不可能生孩子。

据了解,器官移植是目前解决因子宫原因造成不孕不育最有效方法。这让杨女士看到希望。

杨女士的母亲得知自己可能帮助女儿弥补无法生育“遗憾”,便决定将自己的子宫捐献出来。

“为了能让闺女拥有一个‘圆满’的人生,哪怕是要我的命,我都愿意。”

在等待移植的日子里,杨女士顺利地走进了婚姻殿堂。令她感动的,爱人对手术非常支持。

手术难在哪儿?

目前,在医学界,肾脏、肝脏等器官移植技术已成熟。但人的子宫移植并未普遍开展,仅在世界上少数几个国家进行过尝试。据了解,世界上已有多个国家对动物进行子宫移植试验。但真正实施过人子宫移植手术的只有少数几个国家。

据陈必良介绍,子宫位于女性盆腔深部、血管纤细,术中血管切取、缝合难度极大,加之排斥反应强烈,以及围术期护理和治疗面临严峻挑战等原因,至今子宫移植仍是世界性医学难题。

在杨女士的移植手术中,从术前准备到手术实施历经两年时间:前期选择了与人类子宫性状接近的山羊,通过对数对山羊间进行子宫移植,积累在手术、麻醉及抗排斥反应等方面的经验。今年4月和8月,西京医院专家组又对杨女士进行了阴道成形术,并通过辅助生殖技术得到杨女士和她丈夫的受精卵,冷冻起来为后续孕育子女做好准备。

在长达14小时的手术中,专家组先将杨女士母亲的子宫切取,随后将这个子宫放入杨女士体内,并在显微镜下进行了血管吻合手术。术中血液开放后,原本为浅黄色的子宫随着血液的流涌而逐渐变得红润、饱满,超声显示血流平稳顺畅,这证实了血管吻合良好。等患者身体恢复一段时间后,医生将把此前冷冻的受精卵移入新的子宫内,这样杨女士和她丈夫将有望实现做父母的心愿。

11月25日,西京医院副院长李晓康宣布:“中国第一例‘人子宫’移植手术取得成功。目前受体和供体的生命体征都平稳,各项指标正常。”

能否广泛开展?

在我国,因各种原因无法生育的女性不在少数。在女性不孕不育症患者中,有8%是由于先天性无子宫、全子宫切除术、宫腔粘连、严重畸形子宫等子宫因素导致的。因此,子宫移植是治疗不孕不育有效途径。

陈必良表示,子宫移植不仅能解决女性不孕不育问题,单从技术上看,未来将女性子宫移植给男性,实现“男人生孩子”也并非难事。

对此,西京医院伦理委员会成员刘亮说,“虽然男人生孩子在技术上可以实现,但这会扰乱正常的生育秩序,可能引发健康、伦理、法律等多方面问题。”

记者采访了解到,男人生孩子虽然在技术上不难实现,但它涉及伦理、法律等方面问题,因此,对男人来说,这一手术目前无法实施。

刘亮说,在杨女士这例手术中,供方和受体是母女关系,双方是完全自愿实施子宫移植手术的,因此符合医学伦理中的自愿、尊重等原则。虽然未来女儿将用从母亲那里移植来的子宫孕育孩子,但给这个子宫中放置的受精卵来自杨女士夫妻,因此这个孩子的妈妈是谁不会有异议。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1645898, encodeId=ee131645898d0, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Sat Aug 06 06:31:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89017, encodeId=b28f8901e30, content=pbhtff?vnmun, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:59:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89016, encodeId=9eac8901654, content=`的96~2,5jnyjj90~669婆婆nmhbymhu9。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:58:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89015, encodeId=9c72890153c, content=某'tld那天、9(990008809), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:55:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88985, encodeId=2d10889858e, content=厉害,医学在发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Jun 07 20:30:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88966, encodeId=e1ab88966cc, content=有没有二盐酸盐, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf8a1733550, createdName=薰衣草香味, createdTime=Tue Jun 07 16:54:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88961, encodeId=86ec889615b, content=人类的器官, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Jun 07 16:49:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1645898, encodeId=ee131645898d0, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Sat Aug 06 06:31:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89017, encodeId=b28f8901e30, content=pbhtff?vnmun, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:59:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89016, encodeId=9eac8901654, content=`的96~2,5jnyjj90~669婆婆nmhbymhu9。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:58:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89015, encodeId=9c72890153c, content=某'tld那天、9(990008809), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:55:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88985, encodeId=2d10889858e, content=厉害,医学在发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Jun 07 20:30:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88966, encodeId=e1ab88966cc, content=有没有二盐酸盐, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf8a1733550, createdName=薰衣草香味, createdTime=Tue Jun 07 16:54:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88961, encodeId=86ec889615b, content=人类的器官, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Jun 07 16:49:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-06-08 1deef638m61(暂无匿称)

    pbhtff?vnmun

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1645898, encodeId=ee131645898d0, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Sat Aug 06 06:31:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89017, encodeId=b28f8901e30, content=pbhtff?vnmun, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:59:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89016, encodeId=9eac8901654, content=`的96~2,5jnyjj90~669婆婆nmhbymhu9。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:58:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89015, encodeId=9c72890153c, content=某'tld那天、9(990008809), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:55:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88985, encodeId=2d10889858e, content=厉害,医学在发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Jun 07 20:30:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88966, encodeId=e1ab88966cc, content=有没有二盐酸盐, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf8a1733550, createdName=薰衣草香味, createdTime=Tue Jun 07 16:54:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88961, encodeId=86ec889615b, content=人类的器官, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Jun 07 16:49:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-06-08 1deef638m61(暂无匿称)

    `的96~2,5jnyjj90~669婆婆nmhbymhu9。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1645898, encodeId=ee131645898d0, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Sat Aug 06 06:31:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89017, encodeId=b28f8901e30, content=pbhtff?vnmun, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:59:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89016, encodeId=9eac8901654, content=`的96~2,5jnyjj90~669婆婆nmhbymhu9。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:58:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89015, encodeId=9c72890153c, content=某'tld那天、9(990008809), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:55:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88985, encodeId=2d10889858e, content=厉害,医学在发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Jun 07 20:30:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88966, encodeId=e1ab88966cc, content=有没有二盐酸盐, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf8a1733550, createdName=薰衣草香味, createdTime=Tue Jun 07 16:54:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88961, encodeId=86ec889615b, content=人类的器官, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Jun 07 16:49:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-06-08 1deef638m61(暂无匿称)

    某'tld那天、9(990008809)

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1645898, encodeId=ee131645898d0, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Sat Aug 06 06:31:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89017, encodeId=b28f8901e30, content=pbhtff?vnmun, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:59:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89016, encodeId=9eac8901654, content=`的96~2,5jnyjj90~669婆婆nmhbymhu9。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:58:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89015, encodeId=9c72890153c, content=某'tld那天、9(990008809), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:55:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88985, encodeId=2d10889858e, content=厉害,医学在发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Jun 07 20:30:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88966, encodeId=e1ab88966cc, content=有没有二盐酸盐, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf8a1733550, createdName=薰衣草香味, createdTime=Tue Jun 07 16:54:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88961, encodeId=86ec889615b, content=人类的器官, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Jun 07 16:49:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-06-07 明崖

    厉害,医学在发展

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1645898, encodeId=ee131645898d0, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Sat Aug 06 06:31:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89017, encodeId=b28f8901e30, content=pbhtff?vnmun, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:59:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89016, encodeId=9eac8901654, content=`的96~2,5jnyjj90~669婆婆nmhbymhu9。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:58:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89015, encodeId=9c72890153c, content=某'tld那天、9(990008809), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:55:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88985, encodeId=2d10889858e, content=厉害,医学在发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Jun 07 20:30:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88966, encodeId=e1ab88966cc, content=有没有二盐酸盐, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf8a1733550, createdName=薰衣草香味, createdTime=Tue Jun 07 16:54:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88961, encodeId=86ec889615b, content=人类的器官, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Jun 07 16:49:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-06-07 薰衣草香味

    有没有二盐酸盐

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1645898, encodeId=ee131645898d0, content=<a href='/topic/show?id=0e044518543' target=_blank style='color:#2F92EE;'>#子宫移植#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45185, encryptionId=0e044518543, topicName=子宫移植)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d8923252686, createdName=windight, createdTime=Sat Aug 06 06:31:00 CST 2016, time=2016-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89017, encodeId=b28f8901e30, content=pbhtff?vnmun, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:59:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89016, encodeId=9eac8901654, content=`的96~2,5jnyjj90~669婆婆nmhbymhu9。, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:58:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=89015, encodeId=9c72890153c, content=某'tld那天、9(990008809), beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6c51732607, createdName=1deef638m61(暂无匿称), createdTime=Wed Jun 08 07:55:00 CST 2016, time=2016-06-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88985, encodeId=2d10889858e, content=厉害,医学在发展, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73441710184, createdName=明崖, createdTime=Tue Jun 07 20:30:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88966, encodeId=e1ab88966cc, content=有没有二盐酸盐, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf8a1733550, createdName=薰衣草香味, createdTime=Tue Jun 07 16:54:00 CST 2016, time=2016-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88961, encodeId=86ec889615b, content=人类的器官, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/04/24/1c2dbd6706e64df33befd6663f1d6b37.jpg, createdBy=94f61661779, createdName=lyh994, createdTime=Tue Jun 07 16:49:00 CST 2016, time=2016-06-07, status=1, ipAttribution=)]
    2016-06-07 lyh994

    人类的器官

    0

相关资讯

中国首例人子宫移植在西京医院成功实施

25日,大秦网从第四军医大学西京医院“成功实施全国首例子宫移植新闻发布会”上了解到:该院于11月20日成功将陕西安康一位母亲的子宫移入女儿体内。目前患者恢复良好,新移植子宫已经成活。作为国内首例子宫移植,该手术的成功实施,标志着我国在该领域取得突破性进展,为众多先天性无子宫,或后天因肿瘤、产后出血等而被迫切除子宫者带来了福音。女子意外查出无子宫 子宫移植是唯一希望接受移植的这名女子名叫杨华(化名)

盘点:带你了解全世界五花八门的器官移植

在全世界,有面部移植、舌头移植、手部移植、腿部移植和子宫移植---和如今地球第三例和美国第一例阴茎移植。任何身体部分都可能用于移植吗?

美国首例子宫移植术让女性重获生育力

据报道,美国俄亥俄州克利夫兰诊所有望将在接下来的几个月内完成美国首例子宫移植手术。手术的接受者是一些天生缺失子宫、因故切除子宫或子宫受损的女性,通过手术,她们将重获怀孕和生育的能力。但这只是暂时性移植,接受手术的女性在生下一两个孩子后,子宫就要被移除。 科技医学的发展,为治疗提高受孕率提供了新手段 先天性子宫缺失或后天子宫受损都有可能引发女性不孕不育,单纯医药调理不可能解决这种不孕症状。考

仅仅两周!美国首例子宫移植女性摘除植入的子宫

2016年2月24日美国克利夫兰诊所的医生对一名26岁的女性进行了子宫移植手术。2周后,因为女性生殖系统常见微生物感染(细菌引起的阴道酵母菌感染),且子宫血供受累,不得不于3月9日切除移植的子宫。两次手术的间隔仅仅2周时间。因为供体的阴道组织也会参与到手术中,所以当前不知道感染是来自供体还是受体。进行子宫移植的供体女性是一名突然死亡的30来岁女性,受体女性名叫Lindsey McFarland,她

美国首例子宫移植宣告失败,给宝宝修房子哪有那么容易?

导语:觉得试管婴儿一遍遍取卵,植入胚胎,保胎是极其痛苦的事情吗?跟子宫移植相比,根本不值一提。 全球大约每4500名女性中就有1名女性患有先天性子宫阴道缺陷综合症(医学上简称MRKH,即没有子宫)。对于绝对的子宫因素导致的不孕(AUFI),子宫移植似乎是唯一获得“完全亲生孩子”的办法,这将影响到 1/500的生育年龄女性[1]。 风风火火的美国首例子宫移植于2016年2月2

美国完成国内首例子宫移植手术

据外媒报道,美国完成国内第一起子宫移植案例,替没有子宫的女性争取生育机会,这项手术将成为生殖医学的新前沿。医生把一名去世捐赠者的子宫,移植到一个26岁女性体内,手术历经9个小时。病患术后状况稳定,医院将等到下周召开记者会,再详细说明。在美国之前,已经有好几个国家,尝试过子宫移植,瑞典在2014年迎接第一个移植子宫孕育出来的新生儿,目前为止,已经有五个成功生产的案例。医生说,这项手术实际上还处于试验